<info type="ChemicalEntity">dobutamine</info>-induced <info type="DiseaseOrPhenotypicFeature">myocardial ischemia</info>. BACKGROUND: Electrocardiography has a very low sensitivity in detecting <info type="ChemicalEntity">dobutamine</info>-induced <info type="DiseaseOrPhenotypicFeature">myocardial ischemia</info>. OBJECTIVES: To assess the added diagnostic value of a new <info type="GeneOrGeneProduct">cardiac performance index</info> (<info type="GeneOrGeneProduct">dP/dtejc</info>) measurement, based on <info type="GeneOrGeneProduct">brachial artery</info> flow changes, as compared to standard 12-lead <info type="GeneOrGeneProduct">ECG</info>, for detecting <info type="ChemicalEntity">dobutamine</info>-induced <info type="DiseaseOrPhenotypicFeature">myocardial ischemia</info>, using <info type="ChemicalEntity">Tc99m-Sestamibi</info> single-photon emission computed tomography as the gold standard of comparison to assess the presence or absence of <info type="DiseaseOrPhenotypicFeature">ischemia</info>. METHODS: The study group comprised 40 patients undergoing <info type="ChemicalEntity">Sestamibi-SPECT</info>/<info type="ChemicalEntity">dobutamine</info> stress test. Simultaneous measurements of <info type="GeneOrGeneProduct">ECG</info> and <info type="GeneOrGeneProduct">brachial artery dP/dtejc</info> were performed at each <info type="ChemicalEntity">dobutamine</info> level. In 19 of the 40 patients <info type="DiseaseOrPhenotypicFeature">perfusion defects</info> compatible with <info type="DiseaseOrPhenotypicFeature">ischemia</info> were detected on <info type="ChemicalEntity">SPECT</info>. The increase in <info type="GeneOrGeneProduct">dP/dtejc</info> during infusion of <info type="ChemicalEntity">dobutamine</info> in this group was severely impaired as compared to the non-<info type="DiseaseOrPhenotypicFeature">ischemic</info> group. <info type="GeneOrGeneProduct">dP/dtejc</info> outcome was combined with the <info type="GeneOrGeneProduct">ECG</info> results, giving an <info type="GeneOrGeneProduct">ECG</info>-enhanced value, and compared to <info type="GeneOrGeneProduct">ECG</info> alone. RESULTS: The sensitivity improved dramatically from 16% to 79%, positive predictive value increased from 60% to 68% and negative predictive value from 54% to 78%, and specificity decreased from 90% to 67%. CONCLUSIONS: If <info type="GeneOrGeneProduct">ECG</info> alone is used for specificity, the combination with <info type="GeneOrGeneProduct">dP/dtejc</info> improved the sensitivity of the test and could be a cost-savings alternative to <info type="DiseaseOrPhenotypicFeature">cardiac imaging</info> or <info type="DiseaseOrPhenotypicFeature">perfusion studies</info> to detect <info type="DiseaseOrPhenotypicFeature">myocardial ischemia</info>, especially in patients unable to exercise.